Bio Bench has started a partnership with Helixar Biosciences to support its Europe and North America market development.
Helixar Biosciences is focusing on the communication and logistic for Bio Bench products and services. In a first stage, it focused on the SARS-Cov-2 related products but since June 1 it has extended its services to all Bio Bench portfolio.
“To better support the European and Northern American research institutes and biotech industry, we have decided to extend our collaboration with Helixar Biosciences,” added Jiuhua Liu, the CEO of Bio Bench.
About Bio Bench
Bio Bench is a biotechnology CRO company specialized in the development of functional antibodies and biologically active proteins for drug discovery, IVD kit and biological research.
About Helixar Biosciences
Helixar Biosciences is a consulting agency focused on the biotechnology and pharmaceutical market.
For more information, please contact:
Renfeng Liu
General Manager
info@bio-bench.com
+32 497 29 31 19
Let’s block ads! (Why?)
VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…
DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…
KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…
Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…
SINGAPORE - Media OutReach Newswire - 3 May 2024 - UPCX (UPC), a developer of…
DUBLIN--(BUSINESS WIRE)--The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights &…